NDC 42023-179

Buprenorphine Hydrochloride

Buprenorphine Hydrochloride

Buprenorphine Hydrochloride is a Intramuscular; Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is Buprenorphine Hydrochloride.

Product ID42023-179_04db1133-95f5-4f75-849f-7aaa16f00242
NDC42023-179
Product TypeHuman Prescription Drug
Proprietary NameBuprenorphine Hydrochloride
Generic NameBuprenorphine Hydrochloride
Dosage FormInjection
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS
Marketing Start Date2015-07-30
Marketing CategoryANDA / ANDA
Application NumberANDA206586
Labeler NamePar Pharmaceutical, Inc.
Substance NameBUPRENORPHINE HYDROCHLORIDE
Active Ingredient Strength0 mg/mL
Pharm ClassesPartial Opioid Agonists [MoA],Partial Opioid Agonist [EPC]
DEA ScheduleCIII
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 42023-179-05

5 VIAL in 1 CARTON (42023-179-05) > 1 mL in 1 VIAL
Marketing Start Date2015-07-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 42023-179-10 [42023017910]

Buprenorphine Hydrochloride INJECTION
Marketing CategoryANDA
Application NumberANDA206586
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-07-30
Marketing End Date2017-04-10

NDC 42023-179-05 [42023017905]

Buprenorphine Hydrochloride INJECTION
Marketing CategoryANDA
Application NumberANDA206586
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2015-07-30

Drug Details

Active Ingredients

IngredientStrength
BUPRENORPHINE HYDROCHLORIDE.324 mg/mL

OpenFDA Data

SPL SET ID:34767dda-ce52-4f98-a45f-bb5cee0cd5e6
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 238129

    • Pharmacological Class

    • Partial Opioid Agonists [MoA]
    • Partial Opioid Agonist [EPC]
    • Partial Opioid Agonists [MoA]
    • Partial Opioid Agonist [EPC]

    NDC Crossover Matching brand name "Buprenorphine Hydrochloride" or generic name "Buprenorphine Hydrochloride"

    NDCBrand NameGeneric Name
    0143-9246Buprenorphine HydrochlorideBuprenorphine Hydrochloride
    0409-2012Buprenorphine HydrochlorideBuprenorphine Hydrochloride
    0517-0725Buprenorphine HydrochlorideBuprenorphine Hydrochloride
    21695-515Buprenorphine HydrochlorideBuprenorphine Hydrochloride
    35356-556buprenorphine hydrochloridebuprenorphine hydrochloride
    42023-179Buprenorphine HydrochlorideBuprenorphine Hydrochloride
    50090-1571buprenorphine hydrochloridebuprenorphine hydrochloride
    50383-924buprenorphine hydrochloridebuprenorphine hydrochloride
    50383-930buprenorphine hydrochloridebuprenorphine hydrochloride
    53217-246buprenorphine hydrochloridebuprenorphine hydrochloride
    70518-0442buprenorphine hydrochloridebuprenorphine hydrochloride
    63629-4092Buprenorphine hydrochlorideBuprenorphine hydrochloride
    63629-7126buprenorphine hydrochloridebuprenorphine hydrochloride
    64725-1924buprenorphine hydrochloridebuprenorphine hydrochloride
    64725-0930buprenorphine hydrochloridebuprenorphine hydrochloride
    67046-991buprenorphine hydrochloridebuprenorphine hydrochloride
    67046-990buprenorphine hydrochloridebuprenorphine hydrochloride
    70518-2216buprenorphine hydrochloridebuprenorphine hydrochloride
    55700-867BELBUCAbuprenorphine hydrochloride
    12496-0757Buprenexbuprenorphine hydrochloride
    50090-2924BuprenorphineBuprenorphine Hydrochloride
    52440-100Probuphinebuprenorphine hydrochloride
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.